financing
interesting....
convertible debenture with a strike price of .15 plus share warrants with a strike of .22
<
already commitments for over 1/3 without real promotion...
<
the proceeds will be used to develop NEW GEOGRAPHICAL markets and to fund operating and PRODUCT DEVELOPMENT expenses.
<
what i read between the words in capital letters, we are now working to develop CARA in another country (my guess is US) and product development (my guess pay for development of eye tests for cardiovascular issues).
What i find very good about this is we are not getting killed by the price ... on the contrary.
personnal opinion... i like this.
any other views?